Abstract:Tumor angiogenesis plays a pivotal role in the progress of tumor. Among the various endogenous angiogenic inhibitors discovered, the human plasminogen kringle 5 (K5) has been demonstrated to be a potential inhibitor of the proliferation and migration of vascular endothelial cells in vitro. The replication-incompetent adenovirus (Ad) vector Adeno-X-CMV-K5 (Ad-K5) (where CMV is cytomegalovirus) was constructed and its antiangiogenic effect was tested on vascular endothelial cell and tumor cell. For the construction, the K5 cDNA was fused in-frame with human plasminogen signal sequence and inserted into the eukaryotic expression vector pcDNA3 to form pcDNA3K5. The recombinant plasmid was subcloned into the shuttle plasmid pShuttle under the control of the constitutive CMV immediate-early promoter. The plasmid carrying the cDNA for K5 (pShuttleKS) was then recombined with the Adeno-X viral DNA and transformed into E. coli DH5alpha. The resultant recombinant plasmid pAd-K5 was transfected into human embryonic kidney (HEK) 293 cells with liposome. The adenovirus expressing human plasminogen kringle 5 (Ad-K5) was successfully packaged and propagated in 293 cells, as detected by the cytopathic effect (CPE) on the cells, and the viral titer in the supernatant was 5 x 10(8) pfu/mL by plaque assay. Both human umbilical vein endothelial cell line ECV304 and human breast carcinoma cell line MDA-MB-231 were infected with Ad-K5 and Ad-LacZ, which was used the negative control, and assayed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Compared with uninfected control and Ad-LacZ infected control, Ad-K5 infected group at 80 MOI (multiplicity of infection) significantly inhibited ECV304 proliferation; the difference between uninfected control and Ad-LacZ infected control was not significant. In contrast, there was no significant difference in the proliferation of MDA-MB-231 among all the treatments. In addition, the Ad-K5 at 100 MOI inhibited the differentiation and tube formation of ECV304 on ECMatrix gel. These results suggested that the recombinant replication-defective Adenovirus expressing human plasminogen kringle 5 inhibited the proliferation, differentiation and tube formation of ECV304 and had no effect on the proliferation of MDA-MB-231. Adenovirus mediated human plasminogen kringle 5 gene therapy may be a potential treatment of cancer through angiogenesis inhibition.

Conruction of Recombinatn Human Plasminogen Kringle5 Baculovirus Vecotr and Secreted Expression in Myoblast

Construction of Recombinant Human Plasminogen Kringle5 Baculovirus Vector and Secreted Expression in Myoblast

Construction and Expression of Eukaryotic Expression Vector for Recombinant Human Plasminogen Kringle 5 Gene

Cloning Construction and Purification of Recombinant Human Plasminogen Kringle 5 Gene

Cloning and Expression of One Fibrinolytic Enzyme from Bacillus Sp. Zlw-2

Expression And Characterization Of Kingle 1-5 Domains Of Human Plasminogen

Human Plasminogen Kringle 5 Cdna Clone with Eukaryotic System and Identification of Its Expression Product

Study on the Cloning and Expression of Human Fibrinogen Α,β,γ Gene

Study on the Cloning and Expression of Human Fibrinogen α ,β, γ Gene

Expression and Characterization of Kringle 1-4.5 Domains of Human Plasminogen

Construction of Recombinant Adenovirus Carrying Mutant Human Plasminogen Kringle 5 Gene and Expression of K5 Protein

Expression Of Biologically Active Kringle 5 Domain Of Human Plasminogen In Escherichia Coli

Expression, purification, and characterization of recombinant lumbrokinase PI239 in Escherichia coli.

Expression of Human Plasminogen Kringle 5 As Fusion Protein with Truncated Hifnγ Gene in Escherichia Coli

Construction of Recombinant Adenovirus Carrying Kringle 5 Gene and Effects on the Survival of Pulmonary Carcinoma Bearing Mice

Construction and Expression of Eukaryotic Expression Vector for I Kappa B Alpha Mutant Gene

[Preparation and Functional Study of an Adenovirus Vector Expressing Human Plasminogen Kringle 5 Gene].

Expression of Prourokinase (144-411)-annexin V Chimeras in Bombyx Mori Baculovirus Expression Vector System

Construction, expression and identification of recombinant plasmid encoding bifunctional protein sflk1-IFN-gamma]

Construction of Fusion Recombinant Plasmid Coding for RGD Peptide and Urokinase B Chain, Its Expression in Escherichia coil and Preliminary Characterization of Its Biological Activity

Construction of a Host Range-Expanded Hybrid Baculovirus of BmNPV and AcNPV, and Knockout of Cysteinase Gene for More Efficient Expression